YOQNEAM, Israel—Given Imaging—a provider of specialty GI products and a pioneer of capsule endoscopy—today announced the publication of guidelines that provide physicians with a framework for using PillCam COLON 2 in daily clinical practice. The guidelines which were commissioned by the European Society of Gastrointestinal Endoscopy (ESGE) are available online and will be published in the May edition of Endoscopy, the official journal of the ESGE.
The evidence- and consensus-based guidelines are the first to standardize the clinical indications, reporting and work-up for colon capsule endoscopy procedures.
"PillCam COLON 2 gives physicians the option to use a non-invasive and accurate diagnostic exam for direct visualization of the colon," said Cristiano Spada, MD, Catholic University, Rome, Italy. "Since PillCam COLON became commercially available in Europe and other parts of the world in 2009, utilization of this technology to visualize colon mucosa in patients contraindicated for colonoscopy or unwilling to undergo the procedure has increased, as has the number of clinical publications validating its utility. In creating these evidence-based guidelines, our goal was to provide healthcare providers with a standardized protocol to ensure proper patient selection, administration and use of this novel technology in daily practice."
The colon capsule endoscopy guidelines address three key areas of clinical practice. First, the guidelines describe in detail the indications and contraindications for colon capsule endoscopy. Second, the guidelines establish standards for bowel preparation, including diet regimen, the use of boosters, administering prokinetics and patient education about bowel preparation. The guidelines also provide protocols for the report and work-up of colon capsule endoscopy results.
Key consensus conclusions on the use of colon capsule endoscopy include: